1. Executive Summary |
2. Global Metabolomics Services Market Introduction |
2.1. Global Metabolomics Services Market – Taxonomy |
2.2. Global Metabolomics Services Market –Definitions |
2.2.1. Service Type |
2.2.2. Sample Type |
2.2.3. Sample Source |
2.2.4. End User |
2.2.5. Region |
3. Global Metabolomics Services Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Collaborations, Acquisitions and Mergers |
3.6. Global Metabolomics Services Market – Competition Landscape |
3.7. Global Metabolomics Services Market Dynamic Factors – Impact Analysis |
4. Global Metabolomics Services Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 |
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Metabolomics Services Market, By Service Type, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1. Separation and Detection |
5.1.1. Lipidomics |
5.1.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.1.3. Market Opportunity Analysis |
5.1.2. Untargeted Metabolite Assays |
5.1.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.2.3. Market Opportunity Analysis |
5.1.3. Targeted Metabolite Assays |
5.1.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3.3. Market Opportunity Analysis |
5.2. Bioinformatics |
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6. Global Metabolomics Services Market Forecast, By Sample Type, 2017 – 2021 and Forecast, 2022 – 2028 |
6.1. Urine |
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Blood |
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Tumor |
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Cell Culture |
6.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Food Ingredients |
6.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
6.6. Feces |
6.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7. Market Opportunity Analysis Global Metabolomics Services Market Forecast, By Sample Source, 2017 – 2021 and Forecast, 2022 – 2028 |
7.1. Human |
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Animal |
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Others |
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8. Global Metabolomics Services Market Forecast, By End User, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
8.1. Healthcare Industry |
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Academic and Research Institutes |
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Food Processing Industry |
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Others |
8.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
9. Global Metabolomics Services Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
9.1. North America |
9.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia-Pacific |
9.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Latin America |
9.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Middle East and Africa |
9.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
9.6. Global Metabolomics Services Market – Opportunity Analysis Index, By Service Type, By Sample Type, By Sample Source, By End User, and Region, 2022 – 2028 |
10. North America Metabolomics Services Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
10.1. Service Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Separation and Detection |
10.1.1.1. Lipidomics |
10.1.1.2. Untargeted Metabolite Assays |
10.1.1.3. Targeted Metabolite Assays |
10.1.2. Bioinformatics |
10.2. Sample Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.2.1. Urine |
10.2.2. Blood |
10.2.3. Tumor |
10.2.4. Cell Culture |
10.2.5. Food Ingredients |
10.2.6. Feces |
10.3. Sample Source Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.3.1. Human |
10.3.2. Animal |
10.3.3. Others |
10.4. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.4.1. Healthcare Industry |
10.4.2. Food Processing Industry |
10.4.3. Academic Research Institutes |
10.4.4. Others |
10.5. Country Analysis 2016 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
10.5.1. U.S. |
10.5.2. Canada |
10.6. North America Metabolomics Services Market – Opportunity Analysis Index, By Service Type, By Sample Type, By Sample Source, By End User, and Country, 2022 – 2028 |
10.7. North America Metabolomics Services Market Dynamics – Trends |
11. Europe Metabolomics Services Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
11.1. Service Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Separation and Detection |
11.1.1.1. Lipidomics |
11.1.1.2. Untargeted Metabolite Assays |
11.1.1.3. Targeted Metabolite Assays |
11.1.2. Bioinformatics |
11.2. Sample Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.2.1. Urine |
11.2.2. Blood |
11.2.3. Tumor |
11.2.4. Cell Culture |
11.2.5. Food Ingredients |
11.2.6. Feces |
11.3. Sample Source Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Human |
11.3.2. Animal |
11.3.3. Others |
11.4. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.4.1. Healthcare Industry |
11.4.2. Food Processing Industry |
11.4.3. Academic Research Institutes |
11.4.4. Others |
11.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.5.1. Germany |
11.5.2. UK |
11.5.3. France |
11.5.4. Spain |
11.5.5. Italy |
11.5.6. Russia |
11.5.7. Poland |
11.5.8. Rest of Europe |
11.6. Europe Metabolomics Services Market – Opportunity Analysis Index, By Service Type, By Sample Type, By Sample Source, By End User, and Country, 2022 – 2028 |
11.7. Europe Metabolomics Services Market Dynamics – Trends |
12. Asia-Pacific Metabolomics Services Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
12.1. Service Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Separation and Detection |
12.1.1.1. Lipidomics |
12.1.1.2. Untargeted Metabolite Assays |
12.1.1.3. Targeted Metabolite Assays |
12.1.2. Bioinformatics |
12.2. Sample Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.2.1. Urine |
12.2.2. Blood |
12.2.3. Tumor |
12.2.4. Cell Culture |
12.2.5. Food Ingredients |
12.2.6. Feces |
12.3. Sample Source Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Human |
12.3.2. Animal |
12.3.3. Others |
12.4. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.4.1. Healthcare Industry |
12.4.2. Food Processing Industry |
12.4.3. Academic Research Institutes |
12.4.4. Others |
12.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
12.5.1. Japan |
12.5.2. China |
12.5.3. India |
12.5.4. ASEAN |
12.5.5. Australia & New Zealand |
12.5.6. Rest of Asia-Pacific |
12.6. Asia-Pacific Metabolomics Services Market – Opportunity Analysis Index, By Service Type, By Sample Type, By Sample Source, By End User, and Country, 2022 – 2028 |
12.7. Asia-Pacific Metabolomics Services Market Dynamics – Trends |
13. Latin America Metabolomics Services Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
13.1. Service Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.1.1. Separation and Detection |
13.1.1.1. Lipidomics |
13.1.1.2. Untargeted Metabolite Assays |
13.1.1.3. Targeted Metabolite Assays |
13.1.2. Bioinformatics |
13.2. Sample Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.2.1. Urine |
13.2.2. Blood |
13.2.3. Tumor |
13.2.4. Cell Culture |
13.2.5. Food Ingredients |
13.2.6. Feces |
13.3. Sample Source Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.3.1. Human |
13.3.2. Animal |
13.3.3. Others |
13.4. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.4.1. Healthcare Industry |
13.4.2. Food Processing Industry |
13.4.3. Academic Research Institutes |
13.4.4. Others |
13.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
13.5.1. Brazil |
13.5.2. Mexico |
13.5.3. Rest of Latin America |
13.6. Latin America Metabolomics Services Market – Opportunity Analysis Index, By Service Type, By Sample Type, By Sample Source, By End User, and Country, 2022 – 2028 |
13.7. Latin America Metabolomics Services Market Dynamics – Trends |
14. Middle East and Africa Metabolomics Services Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
14.1. Service Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
14.1.1. Separation and Detection |
14.1.1.1. Lipidomics |
14.1.1.2. Untargeted Metabolite Assays |
14.1.1.3. Targeted Metabolite Assays |
14.1.2. Bioinformatics |
14.2. Sample Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.2.1. Urine |
14.2.2. Blood |
14.2.3. Tumor |
14.2.4. Cell Culture |
14.2.5. Food Ingredients |
14.2.6. Feces |
14.3. Sample Source Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.3.1. Human |
14.3.2. Animal |
14.3.3. Others |
14.4. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.4.1. Healthcare Industry |
14.4.2. Food Processing Industry |
14.4.3. Academic Research Institutes |
14.4.4. Others |
14.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
14.5.1. Gulf Cooperation Council (GCC) Countries |
14.5.2. Israel |
14.5.3. South Africa |
14.5.4. Rest of MEA |
14.6. MEA Metabolomics Services Market – Opportunity Analysis Index, By Service Type, By Sample Type, By Sample Source, By End User, and Country, 2022 – 2028 |
14.7. MEA Metabolomics Services Market Dynamics – Trends |
15. Competition Landscape |
15.1. Strategic Dashboard of Top Market Players |
15.2. Company Profiles (Introduction, Financial Analysis, Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
15.2.1. Owl Metabolomics. (Spain), |
15.2.2. Metabolon, Inc. (U.S.), |
15.2.3. Metanomics health (Germany) |
15.2.4. Creative Untargeted Metabolite Analysis (U.S.), |
15.2.5. SteminaBiomarker Discovery, Inc. (U.S.), |
15.2.6. TMIC (Canada) |
15.2.7. West Coast Metabolomics Center (U.S.) |
15.2.8. Lipotype GmbH. (Germany) |
15.2.9. Chenomx Inc. (Canada) |
16. Research Methodology |
17. Key Assumptions and Acronyms |